These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 30015053)
1. Management of leptomeningeal metastasis in breast cancer. Assi HI; Mahmoud T; Saadeh FS; El Darsa H Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053 [TBL] [Abstract][Full Text] [Related]
2. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities. Kak M; Nanda R; Ramsdale EE; Lukas RV J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875 [TBL] [Abstract][Full Text] [Related]
3. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study. Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Niwińska A; Rudnicka H; Murawska M Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959 [TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal metastasis from systemic cancer: Review and update on management. Wang N; Bertalan MS; Brastianos PK Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794 [TBL] [Abstract][Full Text] [Related]
6. Management of leptomeningeal metastases: Prognostic factors and associated outcomes. Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048 [TBL] [Abstract][Full Text] [Related]
7. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis. Lee YC; Hsieh CC; Chuang JP; Li CY Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience. Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641 [TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report. Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855 [TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal disease. Groves MD Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151 [TBL] [Abstract][Full Text] [Related]
12. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM). Niwińska A; Pogoda K; Michalski W; Kunkiel M; Jagiełło-Gruszfeld A J Neurooncol; 2018 May; 138(1):191-198. PubMed ID: 29435818 [TBL] [Abstract][Full Text] [Related]
13. [Three Cases of Intrathecal Chemotherapy with Ventricular Catheter for the Treatment of Leptomeningeal Metastasis from Breast Cancer]. Miyoshi K; Takahashi H; Uno M; Akai M; Moriyama E; Nakagawa T; Nomura T Gan To Kagaku Ryoho; 2018 Dec; 45(12):1767-1769. PubMed ID: 30587738 [TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature. Kapke JT; Schneidewend RJ; Jawa ZA; Huang CC; Connelly JM; Chitambar CR Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):189-193. PubMed ID: 31629723 [TBL] [Abstract][Full Text] [Related]
15. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis]. Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431 [TBL] [Abstract][Full Text] [Related]
16. Complete response of leptomeningeal carcinomatosis secondary to breast cancer. Troussier I; Canova C; Klausner G Breast; 2020 Dec; 54():328-330. PubMed ID: 33278649 [TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of patients with breast cancer-related leptomeningeal metastases. Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer. Le Rhun E; Wallet J; Mailliez A; Le Deley MC; Rodrigues I; Boulanger T; Lorgis V; Barrière J; Robin YM; Weller M; Bonneterre J Neuro Oncol; 2020 Apr; 22(4):524-538. PubMed ID: 31637444 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist]. Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241 [TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal metastasis in breast cancer - a systematic review. Scott BJ; Oberheim-Bush NA; Kesari S Oncotarget; 2016 Jan; 7(4):3740-7. PubMed ID: 26543235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]